v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes  
Schedule of reconciliation of U.S. federal statutory amount and rate to the effective income tax amount and rate

Year Ended December 31, 2025

Year Ended December 31, 2024

  ​ ​ ​

Amount

Percentage

  ​ ​ ​

Amount

Percentage

  ​ ​ ​

Tax benefit at the U.S. statutory rate

 

$

(4,932)

21.0

%  

$

(7,134)

21.0

%  

Foreign Tax Effects

 

Change in valuation allowance

 

%

(373)

1.1

%

Entity dissolution

 

%

373

(1.1)

%

Tax credits

Federal research and development

(671)

2.9

%

(941)

2.8

%

Nontaxable or Nondeductible Items

 

Equity based compensation

481

(2.0)

632

(1.9)

Other

12

(0.1)

%

(4)

%

Change in valuation allowance

 

5,110

(21.8)

%

7,447

(21.9)

%

Tax on Income

 

$

%

$

%

Schedule of deferred tax assets and liabilities

  ​ ​ ​

Year Ended December 31, 

2025

2024

Deferred tax assets:

Net operating loss carryforwards

$

30,907

$

8,491

Tax credit carryforwards

 

4,463

 

3,791

Equity-based compensation

 

312

 

477

Operating lease liabilities

70

114

Capitalized research expenditures

16,089

Deferred grant income

224

Other

 

341

 

324

Deferred tax assets

 

36,093

 

29,510

Less: valuation allowance

 

(36,026)

 

(29,400)

Deferred tax assets after valuation allowance

 

67

 

110

Deferred tax liabilities:

 

  ​

 

  ​

Property and equipment, net

(2)

(4)

Right-of-use assets, operating leases

 

(65)

 

(106)

Deferred tax liabilities

 

(67)

 

(110)

Net deferred tax assets

$

$